Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Wilrijk, Belgium

GSK Investigational Site Munich, Bavaria, Germany

GSK Investigational Site Basel, Switzerland

View Trial Details

Completed

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

NCT00332566

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Capital Federal, Buenos Aires, Argentina

GSK Investigational Site León, Nicaragua

View Trial Details

Completed

Lamivudine and Adefovir to Treat Chronic Hepatitis B

NCT00023309

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Eppelheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 51 locations

View Trial Details

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

NCT00197158

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

NCT00317122

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +20 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Brits, South Africa

GSK Investigational Site Centurion, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

View Trial Details

Completed

Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

NCT00317161

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

NCT00383227

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

NCT00290303

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Manila, Philippines

GSK Investigational Site Quezon City, Philippines

GSK Investigational Site Sampaloc, Manila, Philippines

View Trial Details

Completed

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

NCT00429481

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations: Not specified

View Trial Details

Hepadnaviridae Infections

Hepadnaviridae Infections trial results

Related conditions